
Immunocore CEO: 3rd Big Pharma Eying Unique Cancer Targeting Tech
16/07/2013
0:00
5:10
Immunocore is looking for more licensees for its cancer targeting technology following recent discovery and development deals with GSK and Genentech.
Mais episódios de "The Biopharma Pod"



Não percas um episódio de “The Biopharma Pod” e subscrevê-lo na aplicação GetPodcast.








